| Dr Violeta Nistor, MD | |
|
130 Sc-252, Anderson, SC 29621 | |
| (864) 231-2600 | |
| Not Available |
| Full Name | Dr Violeta Nistor |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 10 Years |
| Location | 130 Sc-252, Anderson, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265750277 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 37985 (South Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Taral Sharma Md Pc | 0244568152 | 13 |
| South Carolina Dept Of Mental Health Accounting Office | 9032021175 | 166 |
News Archive
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today reported results from two ongoing Phase I studies with MLN9708, the first oral proteasome inhibitor being studied in patients with relapsed and/or refractory multiple myeloma.
A rare and powerful type of immune cell has been discovered in the meninges around the brain, suggesting the cells may play a critical but previously unappreciated role in battling Alzheimer's, multiple sclerosis, meningitis and other neurological diseases, in addition to supporting our healthy mental functioning.
VIA Pharmaceuticals, Inc. has announced the issuance of United States Patent No. 7,495,024 entitled "Phenylalkyl N-Hydroxyureas for Combating Atherosclerotic Plaque", covering the use of VIA's lead compound, VIA-2291, for the treatment of atherosclerosis.
If developed countries were to successfully implement five preventive interventions, only a 5% relative reduction in the preterm birth rate could be achieved by 2015, shows a study published by The Lancet.
› Verified 9 days ago
| Entity Name | South Carolina Dept Of Mental Health Accounting Office |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376595041 PECOS PAC ID: 9032021175 Enrollment ID: O20031105000630 |
News Archive
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today reported results from two ongoing Phase I studies with MLN9708, the first oral proteasome inhibitor being studied in patients with relapsed and/or refractory multiple myeloma.
A rare and powerful type of immune cell has been discovered in the meninges around the brain, suggesting the cells may play a critical but previously unappreciated role in battling Alzheimer's, multiple sclerosis, meningitis and other neurological diseases, in addition to supporting our healthy mental functioning.
VIA Pharmaceuticals, Inc. has announced the issuance of United States Patent No. 7,495,024 entitled "Phenylalkyl N-Hydroxyureas for Combating Atherosclerotic Plaque", covering the use of VIA's lead compound, VIA-2291, for the treatment of atherosclerosis.
If developed countries were to successfully implement five preventive interventions, only a 5% relative reduction in the preterm birth rate could be achieved by 2015, shows a study published by The Lancet.
› Verified 9 days ago
| Entity Name | Taral Sharma Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477112597 PECOS PAC ID: 0244568152 Enrollment ID: O20190829002356 |
News Archive
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today reported results from two ongoing Phase I studies with MLN9708, the first oral proteasome inhibitor being studied in patients with relapsed and/or refractory multiple myeloma.
A rare and powerful type of immune cell has been discovered in the meninges around the brain, suggesting the cells may play a critical but previously unappreciated role in battling Alzheimer's, multiple sclerosis, meningitis and other neurological diseases, in addition to supporting our healthy mental functioning.
VIA Pharmaceuticals, Inc. has announced the issuance of United States Patent No. 7,495,024 entitled "Phenylalkyl N-Hydroxyureas for Combating Atherosclerotic Plaque", covering the use of VIA's lead compound, VIA-2291, for the treatment of atherosclerosis.
If developed countries were to successfully implement five preventive interventions, only a 5% relative reduction in the preterm birth rate could be achieved by 2015, shows a study published by The Lancet.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Violeta Nistor, MD 130 Sc-252, Anderson, SC 29621 Ph: (864) 231-2600 | Dr Violeta Nistor, MD 130 Sc-252, Anderson, SC 29621 Ph: (864) 231-2600 |
News Archive
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today reported results from two ongoing Phase I studies with MLN9708, the first oral proteasome inhibitor being studied in patients with relapsed and/or refractory multiple myeloma.
A rare and powerful type of immune cell has been discovered in the meninges around the brain, suggesting the cells may play a critical but previously unappreciated role in battling Alzheimer's, multiple sclerosis, meningitis and other neurological diseases, in addition to supporting our healthy mental functioning.
VIA Pharmaceuticals, Inc. has announced the issuance of United States Patent No. 7,495,024 entitled "Phenylalkyl N-Hydroxyureas for Combating Atherosclerotic Plaque", covering the use of VIA's lead compound, VIA-2291, for the treatment of atherosclerosis.
If developed countries were to successfully implement five preventive interventions, only a 5% relative reduction in the preterm birth rate could be achieved by 2015, shows a study published by The Lancet.
› Verified 9 days ago
Urvi Shah, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 130 Highway 252, Anderson, SC 29621 Phone: 864-231-2600 | |
Abdalla Bamashmus, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 800 N Fant St, Anderson, SC 29621 Phone: 864-512-1810 Fax: 864-512-1805 | |
Joseph M Mcelwee, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2000 E Greenville St, Suite 3700, Anderson, SC 29621 Phone: 864-512-1475 Fax: 864-512-1930 | |
John H Purcell, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 130 Hwy 252, Anderson, SC 29622 Phone: 803-898-8405 | |
Sam Harry Ross, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 130 Highway 252, Anderson, SC 29621 Phone: 803-898-8405 | |
Raymond Kimball, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 130 Highway 252, Anderson, SC 29621 Phone: 803-898-8405 |